Cancer and Metastasis Reviews

, Volume 28, Issue 1–2, pp 77–83

Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility


DOI: 10.1007/s10555-008-9167-2

Cite this article as:
Kim, T.Y., Vigil, D., Der, C.J. et al. Cancer Metastasis Rev (2009) 28: 77. doi:10.1007/s10555-008-9167-2


DLC-1 was originally identified as a potential tumor suppressor. One of the key biochemical functions of DLC-1 is to serve as a GTPase activating protein (GAP) for members of the Rho family of GTPases, particularly Rho A-C and Cdc 42. Since these GTPases are critically involved in regulation of the cytoskeleton and cell migration, it seems clear that DLC-1 will also influence these processes. In this review we examine basic aspects of the actin cyoskeleton and how it relates to cell motility. We then delineate the characteristics of DLC-1 and other members of its family, and describe how they may have multiple effects on the regulation of cell polarity, actin organization, and cell migration.


DLC-1 Cell migration Cell invasion 

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • T. Y. Kim
    • 1
    • 2
  • D. Vigil
    • 1
    • 2
  • C. J. Der
    • 1
    • 2
  • R. L. Juliano
    • 1
    • 2
  1. 1.Department of PharmacologyUniversity of North Carolina School of MedicineChapel HillUSA
  2. 2.Lineberger Comprehensive Cancer CenterUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations